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PMetabolic Syndrome
Distributions of C-Reactive Protein
and its Association With Metabolic
Syndrome in Middle-Aged and Older Chinese People
Xingwang Ye, MSC,* Zhijie Yu, MD, PHD,* Huaixing Li, PHD,* Oscar H. Franco, MD, DSC, PHD,†
Yong Liu, PHD,* Xu Lin, MD, PHD*
Shanghai, China; and Sharnbrook, United Kingdom
Objectives We evaluated the distributions of C-reactive protein (CRP) and its association with metabolic syndrome (MetS) in
middle-aged and older Chinese people.
Background Several studies have suggested that CRP is a risk factor of MetS. However, it remains unclear how CRP levels
are distributed and whether they are associated with MetS in Chinese people.
Methods We conducted a population-based cross-sectional survey in 2005 in Beijing and Shanghai, with a total of 1,458
men and 1,831 women age 50 to 70 years. Metabolic syndrome was defined according to the updated National
Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans.
Results The median CRP level was 0.68 mg/l among the study population. The CRP levels were significantly higher
among participants from Beijing or from urban areas than those in participants from Shanghai or from rural ar-
eas (p  0.01). No gender difference in CRP levels was observed. The prevalence of MetS progressively in-
creased with elevated CRP levels (p  0.0001 for trend). In the highest quartile of CRP levels (1.50 mg/l), the
risk for MetS was substantially higher (odds ratio 5.97; 95% confidence interval 4.75 to 7.51) compared with
that in the lowest quartile of CRP levels (0.33 mg/l) after adjustment for age, gender, geographic location,
lifestyle factors, educational attainment, and family history of chronic diseases. This association was observed in
both obese and nonobese participants.
Conclusions The overall plasma level of CRP is low but highly associated with the MetS among the middle-aged and elderly
Chinese population. Prospective studies are needed to investigate the role of CRP in the development of MetS
and related chronic diseases among Chinese people. (J Am Coll Cardiol 2007;49:1798–805) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.01.065C
(
e
a
w
d
fl
p
d
p
l
t
t
H
(
Wetabolic syndrome (MetS) is characterized as a concur-
ence of abnormalities including abdominal obesity, elevated
lood pressure, dyslipidemia, and hyperglycemia. Owing to
he global epidemic of obesity and sedentary lifestyle, MetS
as become one of the most common health problems not
nly in the West but also in Asia (1). A recent study
eported that, in 1992, the prevalence of MetS among
hinese men and women aged 35 to 64 years was 14.4%
nd 22.0%, respectively, according to the updated National
rom the *Institute for Nutritional Sciences, Shanghai Institutes for Biological
ciences, Chinese Academy of Sciences and Graduate School of the Chinese
cademy of Sciences, Shanghai, China; and †Unilever Corporate Research, Colworth
ark, Sharnbrook, Bedfordshire, United Kingdom. This study was funded by research
rants from the National Natural Science Foundation of China (30371209), the
nnovation Direction Projects of the Chinese Academy of Sciences (KSCX2-2-25),
he Science and Technology Commission of Shanghai Municipality (04DZ14007),
nd the Shanghai-Unilever Research Development Fund (200306).l
Manuscript received September 25, 2006; revised manuscript received January 5,
007, accepted January 15, 2007.holesterol Education Program-Adult Treatment Panel III
NCEP-ATPIII) definition for Asian Americans (2). Gu
t al. (1) observed that the prevalence of MetS was higher
mong women, northern and urban residents compared
ith men, southern and rural individuals based upon the
ata from a national cross-sectional survey in China.
Increasing evidence suggests that chronic low-grade in-
ammation may be part of the “common soil” involving the
athogenesis of MetS, type 2 diabetes, and cardiovascular
isease (CVD) (3). C-reactive protein (CRP), an acute-
hase reactant, is the most extensively studied biomarker of
ow-grade inflammation. Compelling evidence has shown
hat mildly increased CRP is a predictor for CVD (4–6),
ype 2 diabetes (7,8), and MetS (9,10) in healthy people.
owever, CRP levels vary among different populations
11–14), and their relation with these diseases in non-
estern populations remains unclear. In addition, CRP
evels have also been reported to differ by gender (6,14–16)
a
s
a
w
t
p
t
I
C
m
M
S
P
n
B
e
i
d
c
r
r
n
2
c
s
u
p
l
t
r
t
p
d
t
p
i
w
i
I
S
a
D
t
C
n
h
A
l
w
a
d
a
m
p
w
a
o

c
p
e
h
e
s
h
h
t
c
h
w
A
w
i
d
a
l
0
c
c
(
c
l
i
u
7
o
p
a
e
m
m
L
t
f
s
t
c
l
a
a
f
P
n
n
a
s
c
r
1799JACC Vol. 49, No. 17, 2007 Ye et al.
May 1, 2007:1798–805 CRP and Metabolic Syndrome in Chinesend other factors such as obesity, smoking, alcohol con-
umption, and physical activity (17). Existing evidence
lso suggests that CRP might be more strongly correlated
ith MetS in women than in men (6,9,18,19). Never-
heless, most studies have been conducted in Western
opulations, and little is known about the CRP distribu-
ion and its relation with MetS among Chinese people.
n this study, we aimed to investigate the distributions of
RP and its association with MetS in a representative
iddle-aged and elderly Chinese population.
ethods
tudy population. The Nutrition and Health of Aging
opulation in China is a population-based study among
on-institutionalized Chinese people age 50 to 70 years in
eijing and Shanghai, which was designed to investigate the
ffects of environmental and genetic factors and their
nteraction on the development of age-related chronic
iseases. Beijing and Shanghai were selected as the 2 large
ities representing the north and the south of China,
espectively. A multistage sampling method was used to
ecruit the participants. The study was conducted simulta-
eously in both geographic locations from March to June
005. In each city, 2 urban districts and 1 rural district were
hosen to represent people with high to low socioeconomic
tatus. In the sampling process, 400 participants from each
rban district and 800 persons from each rural district were
lanned to be selected randomly from the eligible candidates
isted in the residential registration record. The eligibility of
he candidates was defined as those who were stable
esidents for at least 20 years in the areas and were free from
he following conditions: 1) severe psychological disorders,
hysical disabilities, cancer, CVD, Alzheimer’s disease, or
ementia, within 6 months; or 2) currently diagnosed with
uberculosis, AIDS, and other communicable diseases. One
erson from each household was allowed to participate, and
t was required that at least 40% of the total participants
ere men in each district. All participants provided written
nformed consents. The protocol was approved by the
nstitutional Review Board of the Institute for Nutritional
ciences. A total of 3,289 eligible participants (1,458 men
nd 1,831 women) were recruited.
ata collection. A home interview was conducted by
rained physicians or public health workers from the local
enters for Disease Control and Prevention and commu-
ity hospitals. Data of demographic variables, health status,
ealth behavior, and physical activity (International Physical
ctivity Questionnaire, short last 7-day format) was col-
ected using a standardized questionnaire. Smoking habit
as defined as never, current (daily smoking, 6 months),
nd former (cessation of smoking, 6 months). Alcohol
rinking was grouped into “yes” or “no.” The physical
ctivity level for each individual was classified as low,
oderate, or high according to the questionnaire scoringrotocol (20). Educational attainment of the participants 0as categorized into 3 groups
ccording to the number of years
f education (0 to 6, 7 to 9, and
10 years). Family history of
hronic diseases was considered
ositive if the participants’ par-
nts or siblings had a history of
aving 1 of the following dis-
ases: coronary heart disease,
troke, type 2 diabetes, or
ypertension.
All participants were invited to
ave a physical examination at
he local health stations or the
ommunity clinics after the
ome interview. Participants
ere required to fast overnight.
nthropometric measurements
ere performed by trained med-
cal professionals using a stan-
ardized protocol. Body weight
nd height were measured in
ight indoor clothing without shoes to the nearest 0.1 kg and
.1 cm, respectively. Body mass index (BMI) was then
alculated as weight (kg)/height (m)2. Participants were
ategorized as normal weight (24.0 kg/m2), overweight
24.0 to 27.9 kg/m2), or obese (28.0 kg/m2) (21). Waist
ircumference was obtained at the mid-point between the
owest rib and the iliac crest to the nearest 0.1 cm, after
nhalation and exhalation. Blood pressure was measured by
sing an electronic blood pressure monitor (Omron HEM-
05CP, OMRON Healthcare Inc., Vernon Hills, Illinois)
n the right arm of the participant in a comfortable sitting
osition after at least 5-min rest. Participants were asked to
void vigorous exercise, eating, drinking, smoking, or long
xposure to cold or hot temperatures for 1 h before the
easurement. Three measurements were taken, and the
ean of the last 2 measurements was used for analysis.
aboratory methods. Peripheral venous ethylenediamine-
etraacetic acid blood samples were collected and centri-
uged at 4°C, 3,000 rpm for 15 min. After being frozen, the
amples were shipped in dry ice to the Institute for Nutri-
ional Sciences and stored at 80°C until analysis. Total
holesterol, high-density lipoprotein (HDL) cholesterol,
ow-density lipoprotein (LDL) cholesterol, triglycerides,
nd glucose were measured enzymatically on an automatic
nalyzer (Hitachi 7080, Japan) with reagents purchased
rom Wako Pure Chemical Industries (Osaka, Japan).
lasma CRP was measured by a particle-enhanced immu-
oturbidimetric assay (Ultrasensitive CRP kit, Orion Diag-
ostica, Espoo, Finland) using microparticles coated with
nti-human CRP antibodies. The CRP calibrator was
tandardized against the International Federation of Clini-
al Chemistry reference material (certified reference mate-
ial [CRM] 470). The lower detection limit of the assay was
Abbreviations
and Acronyms
BMI  body mass index
CI  confidence interval
CRM  certified reference
material
CRP  C-reactive protein
CVD  cardiovascular
disease
HDL  high-density
lipoprotein
LDL  low-density
lipoprotein
MetS  metabolic
syndrome
NCEP-ATPIII  National
Cholesterol Education
Program Adult Treatment
Panel III
OR  odds ratio.25 mg/l. The intra-assay coefficients of variation of the
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CRP and Metabolic Syndrome in Chinese May 1, 2007:1798–805RP levels were 6.6%, 0.3%, and 0.8% at 0.62, 3.34, and
.71 mg/l, respectively, while the inter-assay coefficients of
ariation were 11.9%, 2.1%, and 3.4% at 0.59, 5.53, and
.12 mg/l, respectively.
efinition of MetS. The MetS was defined based upon
he updated NCEP-ATPIII for Asian Americans (22) as
resenting 3 or more of the following components: 1) waist
ircumference 90 cm for men or 80 cm for women;
) triglycerides 1.7 mmol/l; 3) HDL cholesterol 1.03
mol/l for men or 1.30 mmol/l for women; 4) blood
ressure 130/85 mm Hg or current use of anti-
ypertensive medications; and 5) fasting glucose 5.6
mol/l or previously diagnosed type 2 diabetes or on oral
ntidiabetic agents or insulin.
tatistical analyses. All undetectable CRP values (0.25
g/l) were replaced with 0.12 mg/l, and natural log trans-
ormations were performed to approximate normality. Gen-
ral linear model for continuous variables and Cochran-
antel-Haenszel statistics for categorical variables were
pplied for the comparison between men and women after
djustment for region (Beijing/Shanghai) and residence
urban/rural). The median level of CRP was tested with
ilcoxon rank sum test when comparing between strata
men and women, Beijng and Shanghai, urban and rural).
pearman partial correlation coefficients of CRP, BMI, and
lements of MetS were calculated after adjusting for age,
ender, and residence. The Kruskal-Wallis test was used to
valuate the association of median CRP levels across num-
ers of MetS components. The prevalence of MetS was
alculated after stratification by gender, region, and resi-
ence, respectively. Multivariate logistic regression models
ere used to estimate the odds ratios (ORs) for the
omponents of MetS or MetS itself. Potential confounding
ariables associated with CRP and the MetS as suggested by
revious publications were controlled in the regression
odels. The variables were age (continuous), smoking,
lcohol drinking, physical activity, education, and family
istory of chronic diseases, along with gender, region, and
esidence. In addition, BMI was considered an intermediate
actor in the regression model to be adjusted further.
nalyses were also repeated in the subgroups of gender,
egion, and residence, respectively. To calculate the ORs for
etS according to the quartile of CRP levels and obesity
tatus, considering the high correlation of BMI with waist
ircumference, we used a modified definition of MetS
composed as having 2 or more MetS components without
entral obesity). Data management and statistical analyses
ere performed with the SAS statistical package version 9.1
SAS Institute, Cary, North Carolina). Statistical tests were
-sided, and a p value 0.05 was considered statistically
ignificant.
esults
haracteristics of the participants. Compared with men,
omen had higher BMI, total cholesterol, LDL cholesterol, tnd HDL cholesterol (all p  0.0001) and lower fasting
lucose (p  0.0005), while men had higher diastolic blood
ressure and waist circumference than women (p  0.0001)
Table 1). A larger proportion of men than women were
urrent smokers (56.1% vs. 5.5%), alcohol drinkers (52.1%
s. 9.9%), and had higher levels of education and physical
ctivity (p  0.0001).
istribution of CRP levels. The median of CRP was 0.68
g/l in the total population. No significant difference in the
RP concentrations was observed between men and women
Table 2). Beijing participants had a higher CRP level than
heir Shanghai counterparts (geometric mean 0.84 vs. 0.60
g/l, p  0.0001). The difference remained significant
fter further adjustment for age, BMI, smoking, alcohol
rinking, physical activity, family history of chronic
iseases, and 4 MetS components (except central obesity)
p  0.0001). Urban participants had a significantly
igher CRP level compared with their rural counterparts
p  0.01), and the difference disappeared when age and
MI were adjusted.
ssociation between CRP and MetS. C-reactive protein
as significantly associated with BMI and waist circumfer-
nce (Table 3). The correlation coefficients between CRP
nd other components of MetS were slightly lower. As
xpected, CRP levels increased gradually with increasing
umbers of MetS components (Fig. 1). The CRP median
or those with 0, 1, 2, 3, 4, and 5 features of MetS were 0.38,
.44, 0.58, 0.93, 1.10, and 1.72 mg/l, respectively (p 
.0001 for trend).
The prevalence of MetS progressively increased from
0.2% to 62.4% across CRP quartiles (Table 4). A similar
rend was observed in each subgroup: male and female,
eijing and Shanghai, and urban and rural residents (all p
.0001 for trend). In each CRP quartile, the prevalence of
he MetS was higher among women, Beijing or urban
esidents compared with their corresponding counterparts.
n addition, the prevalence of each MetS feature (i.e.,
entral obesity, elevated blood pressure, hypertriglyceride-
ia, low HDL cholesterol, and hyperglycemia) increased
rogressively with elevated CRP levels regardless of gender,
egion, or residence (all p  0.0001 for trend).
As expected, increased ORs for the MetS or its compo-
ents were observed from the 1st to the 4th CRP quartiles
p 0.0001 for trend) (Table 5). Compared with the people
n the lowest CRP quartile, those in the highest quartile had
n OR of 5.97 (95% confidence interval [CI] 4.75 to 7.51)
or the MetS, 5.82 (95% CI 4.64 to 7.30) for central obesity,
.32 (95% CI 1.84 to 2.92) for elevated blood pressure, 4.39
95% CI 3.36 to 5.73) for hypertriglyceridemia, 2.81 (95%
I 2.27 to 3.49) for low HDL cholesterol, and 1.86 (95%
I 1.50 to 2.29) for hyperglycemia, respectively, after
djustment for smoking, alcohol drinking, physical activity,
ducation, and family history of chronic diseases along with
ge, gender, region, and residence (model 2). The ORs
ecreased substantially, but were still significant, after fur-
her adjustment for BMI (model 3). The increased risks for
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May 1, 2007:1798–805 CRP and Metabolic Syndrome in Chinesehe MetS corresponding to increased CRP levels were
onsistent among all the subgroups. Marginally higher ORs
or women were observed (p for interaction on gender and
RP quartiles  0.0405) (model 2). However, the interac-
ion between gender and quartiles of CRP became non-
ignificant after further adjustment for BMI.
The risk of MetS was more pronounced among partici-
ants with increased CRP levels and/or BMI (Fig. 2). A
ignificant interaction between CRP and BMI on the risk
Characteristics of Participants*
Table 1 Characteristics of Participants*
Characteristics
Total
(n  3,28
Age (yrs) 58.6 (6.0
SBP (mm Hg) 140.1 (22
DBP (mm Hg) 80.2 (10
BMI (kg/m2) 24.5 (3.6
Waist circumference (cm) 83.7 (10
Total cholesterol (mmol/l) 4.70 (0.9
LDL cholesterol (mmol/l) 3.26 (0.9
HDL cholesterol (mmol/l) 1.28 (0.3
Triglycerides (mmol/l) 1.39 (1.0
Glucose (mmol/l) 5.85 (1.7
Smoking status, n (%)
Never 2,041 (62
Former 329 (10
Current 919 (27
Alcohol drinking, yes, n (%) 940 (28
Physical activity, n (%)
Low 245 (7.5
Moderate 1,381 (42
High 1,663 (50
Education (yrs), n (%)
0–6 1,360 (41
7–9 1,172 (35
10 757 (23
Family history of chronic diseases, n (%) 1,833 (55
*Data are arithmetic mean (SD) unless indicated otherwise. Percenta
comparing men with women, after adjustment for region (Shanghai/B
BMI  body mass index; DBP  diastolic blood pressure; HDL  h
pressure.
-Reactive Protein Concentrationsccording to Gender, Region, and Residence (mg/l)*
Table 2 C-Reactive Protein ConcentrationsAccording to Gender, Region, and Residence (mg/l)*
n
Geometric Mean
(95% CI) Median (IQR)
Total 3,289 0.71 (0.68–0.74) 0.68 (0.33–1.50)
Gender
Men 1,458 0.70 (0.66–0.74) 0.67 (0.33–1.49)
Women 1,831 0.71 (0.68–0.75) 0.69 (0.33–1.54)
Region
Shanghai 1,648 0.60 (0.56–0.63) 0.56 (0.29–1.22)
Beijing 1,641 0.84 (0.79–0.89)† 0.83 (0.38–1.92)†
Residence
Rural 1,649 0.66 (0.63–0.70) 0.64 (0.30–1.44)
Urban 1,640 0.75 (0.71–0.80)‡ 0.72 (0.36–1.57)§
Geometric means were calculated for each subgroup after adjustment for each other, respec-H
ively; †p  0.0001; ‡p  0.001; §p  0.001.
CI  confidence interval; IQR  interquartile range.or MetS was observed (p  0.0052). In the normal weight
roup, participants with the highest CRP level had 67%
igher risk for MetS than those in the lowest CRP quartile
OR  1.67 [95% CI 1.22 to 2.28] for Q4 vs. OR  1.00
or Q1 [reference group]). Among the obese participants,
hose in the 4th CRP quartile had a 4.6-fold OR for MetS
ompared with those in the 1st CRP quartile (OR  15.65
95% CI 9.66 to 25.34] for Q4 vs. OR 3.40 [95% CI 1.73
o 6.67] for Q1).
iscussion
n general, we found that the distribution of CRP levels in
he middle-aged and elderly population in China substan-
ially differed by geographic location. Furthermore, higher
RP levels were associated with an increased risk of MetS,
nd this association was independent of lifestyle factors,
ducation level, family history of chronic diseases, and BMI.
Previous studies have suggested that CRP levels may
e lower in Chinese compared with Caucasian popula-
ions. Anand et al. (12) reported that Chinese living in
anada had the lowest CRP level (median 0.69 mg/l)
hereas South Asian and ‘native Canadians’ had higher
evels compared with Caucasians (median 1.24 mg/l).
imilar results were observed in the Study of Women’s
Men
(n  1,458)
Women
(n  1,831) p Value†
58.8 (5.93) 58.5 (6.1) 0.1449
139.8 (21.4) 140.4 (23.3) 0.3072
82.0 (10.7) 78.7 (10.6) 0.0001
24.1 (3.3) 24.7 (3.8) 0.0001
85.6 (10.5) 82.2 (10.4) 0.0001
4.50 (0.93) 4.85 (0.98) 0.0001
3.08 (0.92) 3.41 (0.99) 0.0001
1.22 (0.33) 1.32 (0.33) 0.0001
1.37 (1.17) 1.40 (0.98) 0.3920
5.97 (1.90) 5.75 (1.59) 0.0005
0.0001
352 (24.1) 1,689 (92.2)
288 (19.8) 41 (2.2)
818 (56.1) 101 (5.5)
759 (52.1) 181 (9.9) 0.0001
0.0001
100 (6.9) 145 (7.9)
553 (37.9) 828 (45.2)
805 (55.2) 858 (46.9)
0.0001
497 (34.1) 863 (47.1)
543 (37.2) 629 (34.4)
418 (28.7) 339 (18.5)
808 (55.4) 1,025 (56.0) 0.8677
ay not sum to 100 because of rounding. †p value was calculated by
and residence (urban/rural).
sity lipoprotein; LDL  low-density lipoprotein; SBP  systolic blood9)
)
.5)
.8)
)
.5)
8)
7)
3)
7)
4)
.1)
.0)
.9)
.6)
)
.0)
.6)
.4)
.6)
.0)
.7)
ges m
eijing)ealth Across the Nation (13): CRP levels in Japanese
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CRP and Metabolic Syndrome in Chinese May 1, 2007:1798–805median 0.5 mg/l) and Chinese (median 0.7 mg/l) were
ower while higher levels were observed in Hispanic and
frican-American compared with Caucasian women
median 1.4 mg/l). Interestingly, the CRP level in our
tudy population was similar to the levels found in
hinese in these 2 studies (12,13). In contrast, Yen et al.
23) reported that the CRP level (median 1.5 mg/l)
mong healthy Chinese men in Taiwan was close to the
evel found in Western studies. However, 37% of the
ubjects had CRP levels below the lowest detectable limit
1.0 mg/l) in their study, and 2,046 of 8,374 were
xcluded for the CRP analysis. Shiesh et al. (24) found
hat the median CRP among healthy individuals age 45
o 81 years in Taiwan was 0.62 mg/l when using a much
ore sensitive assay, which was similar to the result in
he present study. The reason why Chinese and most
ast Asians have significantly lower CRP levels than Western
opulations is unclear. Genetic diversity was reported to
nfluence the baseline level of CRP (25). Relatively low BMI
Figure 1 Distribution of CRP Levels According to the
Numbers of Components of the Metabolic Syndrome
Data are shown as medians (25th and 75th percentiles);
p  0.0001 for trend. CRP  C-reactive protein.
pearman Partial Correlation Coefficients Between CRP, BMI, and
Table 3 Spearman Partial Correlation Coefficients Between CR
CRP SBP DBP
SBP 0.14
DBP 0.16 0.69
BMI 0.32 0.27 0.28
Waist circumference 0.35 0.26 0.32
HDL cholesterol 0.21 0.08 0.11
Triglycerides 0.27 0.19 0.20
Glucose 0.14 0.16 0.15
Adjusted for age, gender, region, and residence. All correlation coefficients were statistically sign
CRP  C-reactive protein; other abbreviations as in Table 1.snd environmental factors such as diet and lifestyle were also
uggested to modulate the CRP concentration (17).
Although the present study further indicated a low overall
RP level in Chinese people, when region or residence was
onsidered, Beijing and urban participants showed
ignificantly higher CRP levels than their Shanghai and
ural counterparts. One plausible explanation for increased
RP level may be the higher prevalence of obesity in
eijing and among urban residents (1). Previous studies
ave showed that higher BMI and waist circumference are
elated to elevated CRP levels (26). In fact, in this study,
fter adjusting for BMI, the differences in the CRP level
etween the regions attenuated remarkably, and the differ-
nces between the residences disappeared. However, the
ifferences between the regions could not be fully explained
y age, BMI, lifestyle factors, family history of chronic
iseases, and MetS components (without central obesity).
ther potential factors such as diet and anti-inflammatory
rugs may also contribute to the differences in CRP levels
17). Consistent with the results from Chinese living in
anada (12) and Taiwan (24), no gender differences were
bserved for CRP levels in our study.
In line with the results in other population studies
6,9,18,19,27–31), the CRP was highly associated with
ndividual MetS features and MetS itself in our study
opulation. A similar association was found between men
nd women in our study after controlling for most
onfounding factors (including BMI) although a slightly
tronger association in women than in men was indicated
n other populations even further adjusted for BMI
9,19). The discrepancy between our study and others
ay be due to the differences in age, BMI, and hormonal
rofiles (6,9,18,19). More studies are needed to explore
hether gender-specific associations between CRP and
etS exist in Chinese people.
Consistent with the studies in other populations
9,10,19), BMI is a pivotal mediator for the association
etween CRP and the MetS in this Chinese population
egardless of gender, region, and residence. However, even
hough BMI has a predominant influence on the CRP
rofile and the overall risk of MetS, data from the current
ents of Metabolic Syndrome*
I, and Elements of Metabolic Syndrome*
BMI
Waist
Circumference
HDL
Cholesterol Triglycerides
0.85
0.35 0.38
0.37 0.40 0.45
0.17 0.22 0.04 0.21
at p  0.05.Elem
P, BMtudy showed that the increased CRP levels per se were
h
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May 1, 2007:1798–805 CRP and Metabolic Syndrome in Chineseighly associated with the individual features of MetS and
etS itself.
Metabolic syndrome is a well-established risk factor for
VD (4–6). Though we did not investigate the relation
etween MetS and CVD, supporting evidence from a recent
tudy showed a 1.7-fold increased risk of CVD among
lderly Chinese people with MetS (32). Based on the high
revalence of Metabolic Syndrome According to Quartile of CRP
Table 4 Prevalence of Metabolic Syndrome According to Quart
Total
Quar
Q1 Q2
<0.33 0.34–0.68
20.2 (168/832) 36.7 (302/824)
Gender
Men 15.5 (58/374) 31.6 (117/370)
Women 24.0 (110/458) 40.8 (185/454)
Region
Shanghai 16.6 (80/482) 31.6 (144/456)
Beijing 25.1 (88/350) 42.9 (158/368)
Residence
Rural 16.8 (78/465) 34.6 (138/399)
Urban 24.5 (90/367) 38.6 (164/425)
ata are % (number with metabolic syndrome/total number within each quartile) for total or stratifi
ubgroup after adjustment for age and each other according to the quartile of C-reactive protein (
dds Ratios and 95% Confidence Interval for MetS and its Individu
Table 5 Odds Ratios and 95% Confidence Interval for MetS and
Q1 Q2
<0.33 0.34–0.68
MetS
Model 1 1.00 2.25 (1.80–2.82)
Model 2 1.00 2.27 (1.81–2.85)
Model 3 1.00 1.57 (1.22–2.03)
Central obesity
Model 1 1.00 2.49 (2.00–3.10)
Model 2 1.00 2.50 (2.01–3.11)
Model 3 1.00 1.49 (1.08–2.04)
Elevated blood pressure
Model 1 1.00 1.34 (1.09–1.64)
Model 2 1.00 1.37 (1.11–1.69)
Model 3 1.00 1.12 (0.90–1.40)
Hypertriglyceridemia
Model 1 1.00 2.27 (1.73–2.99)
Model 2 1.00 2.25 (1.71–2.96)
Model 3 1.00 1.93 (1.46–2.56)
Low HDL cholesterol
Model 1 1.00 1.70 (1.38–2.10)
Model 2 1.00 1.67 (1.35–2.06)
Model 3 1.00 1.36 (1.09–1.69)
Hyperglycemia
Model 1 1.00 1.17 (0.95–1.44)
Model 2 1.00 1.17 (0.95–1.45)
Model 3 1.00 1.04 (0.84–1.29)
odel 1 adjusted for age, gender, region and residence; Model 2 further adjusted for smoking, alc
r hypertension; Model 3 further adjusted for body mass index.
CRP  C-reactive protein; HDL  high-density lipoprotein; MetS  metabolic syndrome.orrelation observed in our study between CRP and MetS,
t is reasonable to assume that an elevated CRP level might
e associated with a higher risk of CVD in Chinese people.
owever, the CRP levels in our population were low, and
pproximately 50% of our participants with MetS had CRP
evels below 1 mg/l (median for participants with MetS:
.04 mg/l), which is considered “low risk” for subsequent
CRP
CRP
p Value for
Trend
Q3 Q4
0.69–1.50 >1.50
50.7 (411/811) 62.4 (513/822) <0.0001
42.8 (151/353) 49.0 (177/361) 0.0001
56.8 (260/458) 72.9 (336/461) 0.0001
46.5 (184/396) 53.5 (168/314) 0.0001
54.7 (227/415) 67.9 (345/508) 0.0001
45.5 (176/387) 58.0 (231/398) 0.0001
55.4 (235/424) 66.5 (282/424) 0.0001
ender, region, and residence, respectively. The p value for trend was calculated for total and each
espectively.
mponents According to Quartile of CRP
ndividual Components According to Quartile of CRP
ile of CRP
p Value
for Trend
Q3 Q4
0.69–1.50 >1.50
3.88 (3.11–4.86) 6.10 (4.86–7.65) 0.0001
3.83 (3.06–4.80) 5.97 (4.75–7.51) 0.0001
2.16 (1.68–2.80) 3.01 (2.32–3.92) 0.0001
4.75 (3.81–5.93) 5.90 (4.71–7.39) 0.0001
4.66 (3.73–5.82) 5.82 (4.64–7.30) 0.0001
2.47 (1.79–3.40) 2.40 (1.73–3.34) 0.0001
1.65 (1.33–2.05) 2.33 (1.86–2.93) 0.0001
1.60 (1.28–1.98) 2.32 (1.84–2.92) 0.0001
1.13 (0.90–1.42) 1.50 (1.17–1.91) 0.0130
3.15 (2.41–4.12) 4.52 (3.47–5.89) 0.0001
3.11 (2.37–4.07) 4.39 (3.36–5.73) 0.0001
2.38 (1.80–3.14) 3.02 (2.29–3.99) 0.0001
2.02 (1.64–2.50) 2.93 (2.36–3.62) 0.0001
1.97 (1.59–2.44) 2.81 (2.27–3.49) 0.0001
1.38 (1.11–1.73) 1.77 (1.41–2.23) 0.0001
1.51 (1.23–1.87) 1.86 (1.51–2.29) 0.0001
1.50 (1.21–1.85) 1.86 (1.50–2.29) 0.0001
1.23 (0.99–1.53) 1.42 (1.14–1.77) 0.0067
inking, physical activity, education, and family history of coronary heart disease, stroke, diabetes,ile of
tile ofal Co
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CRP and Metabolic Syndrome in Chinese May 1, 2007:1798–805VD according to the criteria proposed by Centers for
isease Control and Prevention and the American Heart
ssociation (33). The criteria were mainly generated from
tudies performed in Caucasian populations. Hence, pro-
pective studies are warranted to investigate CRP, MetS,
nd other risk factors related to CVD to verify whether the
uggested cutoff points are valid in the Chinese population.
To our knowledge, this is the first large-scale, population-
ased study to investigate CRP distribution and its relation
ith updated NCEP-ATPIII MetS among both genders in
hina. One of the advantages of this study was that
articipants had been recruited from the north (Beijing) and
he south (Shanghai) and urban and rural areas, represent-
ng a relatively wide range of middle-aged and older
hinese people. In addition, most confounding factors for
he risk of MetS in this study were carefully taken into
onsideration in the regression analyses. Furthermore, the
eld study was done within a relatively short period of time;
hus the seasonal influence on the biomarkers and other
ifestyle factors was minimized.
Admittedly, with the cross-sectional nature, it is not
ossible to establish a cause-effect relationship between
RP levels and MetS. In addition, a relatively large pro-
ortion (16.5%) of our study population had a CRP level
elow the detectable limit due to the overall low CRP level
n the Chinese population. Nonetheless, the assay was
tandardized to the reference material 470, and the CRP
evels in our study were consistent with those reported in the
iterature in which CRP kits were also standardized to
RM 470 (12,13,24). Finally, only 1 fasting blood sample
Figure 2 Adjusted Odds Ratios for Modified Metabolic Syndrom
Adjusted for age, gender, region, residence, smoking, drinking, physical activity, ed
sion (p  0.0052 for interaction of C-reactive protein [CRP] and obesity status). M
syndrome without central obesity.as collected, and the magnitude of the intra-individualariation on the CRP concentration, lipids, and glucose
ould not be determined.
onclusions
ur study indicates that the overall CRP level in both
enders is low and varies with regions and residences among
he middle-aged and older Chinese population. There is a
trong association between the CRP level and the MetS.
onsidering the high prevalence of the MetS accompanied
ith low CRP level in the Chinese population, prospective
tudies with solid end points of diabetes and CVD are
eeded to establish biologically relevant CRP cutoff points
or future risk assessment and disease prevention.
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